Clinical Trial

The Effect of Dose and Storage Conditions of Indocyanine Green on Efficacy and Cost in Sentinel Lymph Node Mapping in Gynecological Cancer

Study acronym: DOSTCONICG
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 2, 2026 (before its estimated August 3, 2026 completion). Its status may not reflect the trial's current state.
Summary
This research will determine the impact of optimizing dosage and storage conditions for indocyanine green on health outcomes and will contribute to improving treatment processes in gynecological cancers. Ultrastaging will increase the detection of micrometastases. Furthermore, the cost impact of these optimizations will be evaluated. It will help develop more effective, safe, and cost-effective methods for sentinel lymph node mapping in gynecological cancers. Furthermore, significant savings in healthcare costs could be achieved.
Trial Details
NCT Number NCT07380698
Lead Sponsor Cukurova University
Conditions Endometrial Cancer, Vulvar Cancers, Cervical Cancer, Indocyanine Green (ICG)
Enrollment 30 participants
Start Date 2025-10-03
Primary Completion 2026-08-03 (estimated)
Study Completion 2026-09-03 (estimated)
Updated on ClinicalTrials.gov 2026-02-02